To sign up for our newsletter, please click here.
Large Employers See Costs for Addiction Treatment Escalate
The human toll of the nationwide opioid epidemic has been evident for several years now. But how much of a financial cost does it impose?
Researchers for the Kaiser Family Foundation wanted a better understanding of the financial impact on one very specific segment: those covered by insurance provided by large employers—nearly 31% of all Americans.
Here are some of the key findings of the Kaiser study, “A Look at How the Opioid Crisis Has Affected People with Employer Coverage”:
- About four in 10 opiod addicts are covered by private health insurance. That’s about the same for those covered by Medicaid.
- The frequency of prescribing opioids for those covered by large employers increased from 2004 until peaking in 2009. “By 2016, the share was even lower, at 13.6% (a 21% decline since 2009).”
- While opioid prescriptions have gone down, the costs of treating addiction and overdoses (from both prescription and illegal opioids) have jumped dramatically for large employers. Costs increased ninefold from $300 million in 2004 to $2.6 billion in 2016.
- “Average outpatient expenses totaled $4,695 (of which $670 was paid out of pocket) in 2016. Among those with inpatient spending on treatment for opioid misuse, average inpatient expenses totaled $16,104 (with $1,628 paid out of pocket) in 2016. On average, inpatient expenses have risen sharply, up from $5,809 in 2004.”
- “The bulk of spending by people with large employer coverage on inpatient and outpatient treatment for opioid addiction and overdose was for employees’ children (53%) or spouses (18%), while just under a third (29%) was for employees themselves.”